注射剂原研药与仿制药的政府定价比较

目的:为完善药品政府定价,特别是对于原研药的定价提供参考。方法:通过统计国家发改委药品定价目录中的价格数据,计算注射剂中原研药与仿制药价格的差价率。结果:满足《药品政府定价办法》中对于差价率规定(注射剂差价率35%)的药品仅占总数的26%,且最高的一个差价率超过500%。结论:建议政府采用逐步降价等较温和方法,控制给予原研药的价格优惠程度,并建立动态的价格调控机制,使原研药生产企业与仿制药生产企业利益趋于平衡。

Brand-name Injectable Drugs vs. Generic Injection in Governmental Pricing

OBJECTIVE： To provide references for improving the governmental drug pricing, especially for brand-name drugs. METHODS： With the statistical data listed in the governmental drug price catalogs, the price difference rates between brand - name and generic injection were computed. RESULTS： Only 26% of the drugs were in line with the requirement on price difference rate （35% for injections） specified in governmental drug price principle, and the highest price gap between brand- name drug and generic drug was as high as over 500%. CONCLUSIONS： It is advisable for government to adopt mild method of gradual reduction of drug prices, control the preferential degree for the price of the brand- name drugs, establish a dynamic price control system, and promote the balance on the benefits of both brand - name drug manufactures and the generic drug manufacturers.